Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa

J Infect Dis. 2019 Apr 16;219(9):1456-1463. doi: 10.1093/infdis/jiy692.

Abstract

Background: HLA class I contributes to HIV immune control through antigen presentation to cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. In contrast to investigations of CTL, studies of NK cells in HIV control through HLA-killer immunoglobulin-like receptor (KIR) interactions remain sparse in African cohorts.

Methods: Treatment-naive, chronically HIV-infected adults (N = 312) were recruited from South Africa, and the effects of HLA-KIR pairs on clinical outcome were analyzed.

Results: There was no significant difference in viral load among all subjects with HLA alleles from the HLA-C1 group (P = .1). However, differences in HLA-C type significantly influenced viremia among 247 KIR2DL3 positives (P = .04), suggesting that specific HLA-KIR interactions contribute to immune control. Higher viral load (P = .02) and lower CD4+ T-cell counts (P = .008) were observed in subjects with HLA-C*16:01+KIR2DL3+. Longitudinal analysis showed more rapid progression to AIDS among HLA-C*16:01+KIR2DL3+ subjects (adjusted hazard ratio 1.9, P = .03) than those without this genotype, independent of CD4+ T-cell count and viral load.

Conclusions: These results highlight the existence of unique anti-HIV innate immunity within distinct populations and the contribution of KIR on NK cells and some CTLs to the well-described HLA-mediated impact on HIV disease progression.

Keywords: HIV; HLA; KIR; South Africa; disease outcome.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Chronic Disease
  • Disease Progression
  • Female
  • Gene Frequency
  • Genes, MHC Class I / genetics
  • Genotype
  • HIV Infections / drug therapy
  • HIV Infections / genetics*
  • HIV Infections / immunology*
  • HLA-B Antigens / genetics
  • HLA-C Antigens / genetics*
  • HLA-E Antigens
  • Histocompatibility Antigens Class I / genetics
  • Humans
  • Immunity, Innate
  • Linkage Disequilibrium
  • Male
  • NK Cell Lectin-Like Receptor Subfamily C / genetics
  • Receptors, KIR2DL1 / genetics
  • Receptors, KIR2DL3 / genetics*
  • South Africa
  • Treatment Outcome
  • Viral Load

Substances

  • Anti-HIV Agents
  • HLA-B Antigens
  • HLA-C Antigens
  • Histocompatibility Antigens Class I
  • KIR2DL1 protein, human
  • KIR2DL3 protein, human
  • KLRC1 protein, human
  • NK Cell Lectin-Like Receptor Subfamily C
  • Receptors, KIR2DL1
  • Receptors, KIR2DL3